BioCentury | Sep 19, 2011
Clinical News

OvPlex update

...Mark approval in Europe and is approved in Australia. CytogenDx Co. Ltd. , Wuxi, China HealthLinx Ltd....
BioCentury | Sep 20, 2010
Clinical News

OvPlex: Pivotal trial started

...distribute the diagnostic. OvPlex has CE Mark approval in Europe and is approved in Australia. HealthLinx Ltd....
BioCentury | Sep 13, 2010
Company News

HealthLinx, Inex Innovations Exchange, Quest Laboratories, Medison sales and marketing update

...for 10 years. Medison is responsible for regulatory approval. HealthLinx is eligible for double-digit royalties. HealthLinx Ltd....
BioCentury | Jun 28, 2010
Clinical News

Next-generation OvPlex panel: Biomarker trial started

...women. The trial is being partially funded by the Victorian Government's Science Agenda Investment Fund. HealthLinx Ltd....
BioCentury | Jun 28, 2010
Clinical News

Next-generation OvPlex panel: Pivotal trial started

...South Korean pivotal trial to evaluate its next-generation OvPlex panel in samples from 220 women. HealthLinx Ltd....
BioCentury | Aug 10, 2009
Clinical News

OvPlex regulatory update

...in 4Q09. The test, which measures 5 biomarkers in blood, is already marketed in Australia. HealthLinx Ltd....
BioCentury | Aug 10, 2009
Clinical News

OvPlex: Additional Phase II data

...Nov. 19, 2007). OvPlex has CE Mark approval in Europe and is approved in Australia. HealthLinx Ltd....
BioCentury | Dec 15, 2008
Clinical News

2nd generation OvPlex panel: Phase II data

...this year, the company launched its first-generation OvPlex panel in Australia (see BioCentury, Nov. 3). Healthlinx Ltd....
BioCentury | Nov 3, 2008
Company News

Analytical Reference Laboratories Pty. Ltd., HealthLinx sales and marketing update

...by HealthLinx and costs about A$200 (US$122). Analytical Reference Laboratories Pty. Ltd. , Melbourne, Australia HealthLinx Ltd....
BioCentury | Feb 25, 2008
Company News

HealthLinx board of directors update

HealthLinx Ltd. (ASX:HTX), Melbourne, Australia Business: Proteomics, Cardiovascular Appointed: Co-founder Gregory Rice as non-executive chairman WIR Staff...
Items per page:
1 - 10 of 15
BioCentury | Sep 19, 2011
Clinical News

OvPlex update

...Mark approval in Europe and is approved in Australia. CytogenDx Co. Ltd. , Wuxi, China HealthLinx Ltd....
BioCentury | Sep 20, 2010
Clinical News

OvPlex: Pivotal trial started

...distribute the diagnostic. OvPlex has CE Mark approval in Europe and is approved in Australia. HealthLinx Ltd....
BioCentury | Sep 13, 2010
Company News

HealthLinx, Inex Innovations Exchange, Quest Laboratories, Medison sales and marketing update

...for 10 years. Medison is responsible for regulatory approval. HealthLinx is eligible for double-digit royalties. HealthLinx Ltd....
BioCentury | Jun 28, 2010
Clinical News

Next-generation OvPlex panel: Biomarker trial started

...women. The trial is being partially funded by the Victorian Government's Science Agenda Investment Fund. HealthLinx Ltd....
BioCentury | Jun 28, 2010
Clinical News

Next-generation OvPlex panel: Pivotal trial started

...South Korean pivotal trial to evaluate its next-generation OvPlex panel in samples from 220 women. HealthLinx Ltd....
BioCentury | Aug 10, 2009
Clinical News

OvPlex regulatory update

...in 4Q09. The test, which measures 5 biomarkers in blood, is already marketed in Australia. HealthLinx Ltd....
BioCentury | Aug 10, 2009
Clinical News

OvPlex: Additional Phase II data

...Nov. 19, 2007). OvPlex has CE Mark approval in Europe and is approved in Australia. HealthLinx Ltd....
BioCentury | Dec 15, 2008
Clinical News

2nd generation OvPlex panel: Phase II data

...this year, the company launched its first-generation OvPlex panel in Australia (see BioCentury, Nov. 3). Healthlinx Ltd....
BioCentury | Nov 3, 2008
Company News

Analytical Reference Laboratories Pty. Ltd., HealthLinx sales and marketing update

...by HealthLinx and costs about A$200 (US$122). Analytical Reference Laboratories Pty. Ltd. , Melbourne, Australia HealthLinx Ltd....
BioCentury | Feb 25, 2008
Company News

HealthLinx board of directors update

HealthLinx Ltd. (ASX:HTX), Melbourne, Australia Business: Proteomics, Cardiovascular Appointed: Co-founder Gregory Rice as non-executive chairman WIR Staff...
Items per page:
1 - 10 of 15